FDA approves first oral hormone therapy for advanced prostate cancer
Orgovyx (relugolix) is now approved to treat advanced prostate cancer and is the first oral hormone therapy approved for this indication, the U.S. Food and Drug Administration announced Friday.
Dec 22, 2020
0
7